Development and validation of a repharsed phase- HPLC method for simultaneous determination of rosiglitazone and glimepiride in combined dosage forms and human plasma

Chemistry Central Journal

Volumn 6, Issue 1, 2012, Pages

  El Enany, Nahed M ^a   Abdelal, Amina A ^a   Belal, Fathalla F ^a   Itoh, Yoshinori I ^b   Nakamura, Mitsuhiro N ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b GIFU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Glimepiride (GLM); HPLC; Human plasma; Rosiglitazone (ROS)

Indexed keywords

EID: 84856082804     PISSN: None     EISSN: 1752153X     Source Type: Journal    
DOI: 10.1186/1752-153X-6-9     Document Type: Article

References (19)

1. Balfour JA, Plosker GL. Rosiglitazone. Drugs 1999, 57(6):921-30. 10.2165/00003495-199957060-00007, 10400405.
2. AVANDARYL® (rosiglitazone maleate and glimepiride) Tablets. , http://www.medicineonline.com/drugs/A/4200/AVANDARYL-rosiglitazone-maleate-and-glimepiride-Tablets.html
3. Gomes P, Steppe M. First-derivative spectrophotometry in the analysis of rosiglitazone in coated tablets. J AOAC Int 2006, 89:1296-1299.
4. Walash MI, El-Brashy A, El-Enany N, Kamel ME. Spectrofluorimetric and spectrophotometric determination of rosiglitazone maleate in pharmaceutical preparations and biological fluids. Pharmaceutical Chemistry Journal 2009, 43:697-709.
5. El Sherbiny D, El-Enany N, Belal F. Voltammetric Determination of Rosiglitazone in Pharmaceutical Preparations and Human Plasma. Anal Lett 2008, 41:806-821.
6. Ali AR, Duraidi II, Saket MM, Abu-Nameh ES. Column high-performance liquid chromatographic method for the simultaneous determination of rosiglitazone and metformin in a pharmaceutical preparation. J AOAC Int 2009, 92:119-124.
7. Kang X, Wang F, Xie Z, Li H. A high performance liquid chromatography method for simultaneous determination of rosiglitazone and gemfibrozil in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009, 877:645-648. 10.1016/j.jchromb.2009.01.001, 19208502.
8. Yu J, Ma K, Qi J, Jin G, Wang Y, Fang S, Li G. Bioequivalence and comparison of pharmacokinetic properties of 4-mg tablet formulations of rosiglitazone hydrochloride and rosiglitazone maleate: a single-dose, randomized, open-label, two-period crossover study in healthy adult male Chinese volunteers. Clin Ther 2008, 30:2272-2279. 10.1016/j.clinthera.2008.12.011, 19167587.
9. Altinöz S, Tekeli D. Analysis of glimepiride by using derivative UV spectrophotometric method. J Pharm Biomed Anal 2001, 24:507-515. 10.1016/S0731-7085(00)00445-3, 11199230.
10. Ma HL, Xu MT, Qu P, Ma XH. Polarographic behavior and determination of glimepiride. Yao Xue Xue Bao 2005, 40:750-753.
11. A K, G S, C MR, Bhat K, A R, P M, M S, K K, N U. Simultaneous determination of pioglitazone and glimepiride in bulk drug and pharmaceutical dosage form by RP-HPLC method. Pak J Pharm Sci 2008, 21:421-425.
12. Jain D, Jain S, Jain D, Amin M. Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride, and glimepiride by RP-HPLC in tablet formulation. J Chromatogr Sci 2008, 46:501-504.
13. Chakradhar L, Kallem R, Karthik A, Sundari BT, Ramesh S, Mullangi R, Srinivas NR. A rapid and highly sensitive method for the determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pre-clinical pharmacokinetic study. Biomed Chromatogr 2008, 22:58-63. 10.1002/bmc.896, 17642067.
14. Goyal A, Singhvi I. Simultaneous spectrophotometric estimation of rosiglitazone maleate and glimepiride in tablets dosage forms. Indian Journal Pharm Sci 2007, 69:780-783.
15. ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures Text and Methodology, Q2(R1). Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 1996, Incorporated in November 2005. [http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf](accessed February 15, 2008).
16. Miller JN, Miller JC. Statistics and Chemometrics for Analytical Chemistry 2005, 256. Pearson Education Limited, Harlow, England, 5.
17. GlaxoSmithKline AV. L19, PRESCRIBING INFORMATION. (accessed March, 2007)., http://www.gsk-ecs.com/news/private/Avandia AV L19 P.I.pdf
18. Moffat AC, Osselton MD, Widdop B. Clark's Analysis of Drugs and Poisons in Pharmaceuticals, Body fluids and Postmortem Material. 2004, 1081. The Pharmaceutical Press, London, 3.
19. Hruska MW, Frye RF. Simplified method for determination of rosiglitazone in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2004, 803:317-320. 10.1016/j.jchromb.2004.01.010, 15063342.